| Literature DB >> 15249634 |
S Helisalmi1, B Dermaut, M Hiltunen, A Mannermaa, M Van den Broeck, M Lehtovirta, A M Koivisto, S Iivonen, M Cruts, H Soininen, C Van Broeckhoven.
Abstract
The authors previously reported that genetic variation in the gene coding for nicastrin (NCSTN) modified risk for familial early-onset Alzheimer disease (AD) in a Dutch population-based sample. Risk was highest in patients without an APOE epsilon4 allele. Here, they evaluated if NCSTN polymorphisms increased risk of AD in the eastern Finnish population. A significant difference in one haplotype was observed in AD patients without the APOE epsilon4 allele.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15249634 DOI: 10.1212/01.wnl.0000133153.98139.4e
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910